Literature DB >> 10961580

D-dimer for the diagnosis of venous thromboembolism.

D R Anderson1, P S Wells.   

Abstract

D-dimer, a breakdown product of cross-linked fibrin has been extensively evaluated as a diagnostic test for acute venous thromboembolism. Rapid, highly sensitive D-dimer assays are now available that are suitable for testing in the emergency setting. Preliminary studies suggest that when using a highly sensitive D-dimer assay, a negative test result may,be sufficient to exclude the diagnosis of venous thromboembolism without need for further testing. Less sensitive, but more specific D-dimer assays are also available. The negative predictive value of these latter assays is insufficient to exclude venous thromboembolism on the basis of a negative test result alone. However, their utility is increased by identifying patient populations at low risk for venous thromboembolism using consideration of clinical probability or radiographic testing. Further, large multicenter management studies are required to confirm the safety of relying on a negative D-dimer result to exclude the diagnosis of venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961580     DOI: 10.1097/00062752-200009000-00007

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  4 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation.

Authors:  Ezekiel Uba Nwose
Journal:  N Am J Med Sci       Date:  2010-08

3.  Whole blood viscosity assessment issues II: Prevalence in endothelial dysfunction and hypercoagulation.

Authors:  Ezekiel Uba Nwose
Journal:  N Am J Med Sci       Date:  2010-06

4.  The diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE).

Authors:  Zhihui Fu; Xibin Zhuang; Yueming He; Hong Huang; Weifeng Guo
Journal:  J Cardiothorac Surg       Date:  2020-07-20       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.